Compare GROY & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | GROY | YDES |
|---|---|---|
| Founded | 2020 | 2013 |
| Country | Canada | Taiwan |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 938.2M | 894.2M |
| IPO Year | 2021 | N/A |
| Metric | GROY | YDES |
|---|---|---|
| Price | $4.94 | $11.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.15 | N/A |
| AVG Volume (30 Days) | ★ 3.0M | 57.9K |
| Earning Date | 11-05-2025 | 09-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $14,464,000.00 | $510,360.00 |
| Revenue This Year | $72.11 | N/A |
| Revenue Next Year | $100.63 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 86.30 | 45.76 |
| 52 Week Low | $1.20 | $5.30 |
| 52 Week High | $5.05 | $31.00 |
| Indicator | GROY | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 75.93 | N/A |
| Support Level | $4.16 | N/A |
| Resistance Level | $4.45 | N/A |
| Average True Range (ATR) | 0.19 | 0.00 |
| MACD | 0.07 | 0.00 |
| Stochastic Oscillator | 90.54 | 0.00 |
Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.